-
August 16, 2017
Enteromedics Inc. announced the closing of their Underwritten offering in the amount of $18,295,000. EG&S acted as counsel to the Underwriter.
-
August 11, 2017
BioAmber Inc. announced the closing of their Underwritten offering in the amount of $11,000.000. EG&S acted as counsel to the Underwriter.
-
August 02, 2017
Integrity Applications, Inc. announced the closing of their PIPE offering in the amount of $12,000,000. EG&S acted as counsel to the Placement Agent.
-
August 01, 2017
Industrea Acquisition Corp. announced the closing of its initial public offering in the amount of $230,000,000. EG&S acted as counsel to the underwriters.
-
July 28, 2017
Titan Medical Inc. announced the closing of its registered offering in the amount of $7,356,682. EG&S acted as counsel to Maxim Group LLC, who acted as co-placement agent in the offering.
-
July 26, 2017
Douglas S. Ellenoff, a member of the Firm, was interviewed by Crowdfund Insider on ICOs (Initial Coin Offerings). The Securities and Exchange Commission (SEC) issued an investigative report on the fast growing Initial Coin Offering market that will squelch the ICO market, at least in the US.
Click here to read the full article.
-
July 25, 2017
Apollo Endosurgery Inc. announced the closing of their Underwritten offering in the amount of $35,983,491. EG&S acted as counsel to the Underwriter.
-
July 24, 2017
ImmunoCellular Therapeutics, Ltd. announced the closing of its public offering in the amount of $5,000,000. EG&S acted as counsel to Maxim Group LLC, the sole book-running manager for the offering.
-
July 21, 2017
Trovagene, Inc., a precision medicine biotechnology company, announced the closing of their Registered Direct offering in the amount of $7.1 million. EG&S acted as counsel to Maxim Group LLC, the Sole Placement Agent for Trovagene.
-
July 21, 2017
Cyclacel Pharmaceuticals Inc. announced the closing of their Underwritten offering in the amount of $4,306,360. EG&S acted as counsel to the Underwriter.
-
July 20, 2017
The Deal issued its quarterly PIPE League Tables, revealing that the second quarter of 2017 saw 339 deals, raising $19.14 billion. The quarter was down from the comparable period last year, when the same number of deals yielded almost $24 billion after a rebound in oil prices sent energy companies roaring back into the market. Data is sourced from PrivateRaise, a service of The Deal, which tracks PIPEs that raise at least $1 million.
EG&S is top ranked. Click here to read the full article.
-
July 18, 2017
Douglas S. Ellenoff, a member of the Firm, was interviewed by Crowdfund Insider on ICOs (Initial Coin Offerings). Read the full article here.
-
July 14, 2017
EG&S was honored with ringing the Opening Bell at NASDAQ in celebration of our 25th Anniversary!
-
July 10, 2017
Nxt-ID, Inc. announced the pricing of concurrent registered direct and private placement offerings yielding gross proceeds to the company of $3,432,000. EG&S acted as counsel to Aegis Capital Corp., the sole placement agent for these offerings.
-
July 07, 2017
Yield10 Bioscience, Inc. announced the closing of their Registered Direct offering in the amount of $2,283,136. EG&S acted as counsel to the Placement Agent.
-
July 07, 2017
M III Acquisition Corp. announced that it priced its initial public offering in the amount of $150,000,000. EG&S acted as counsel to M III.
-
July 05, 2017
Prima BioMed Ltd. announced the closing of its Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to Maxim Group, the Sole Placement Agent for the offering.
-
June 28, 2017
Hennessy Capital Acquisition Corp. III announced the closing of its initial public offering in the amount of $225,000,000. EG&S acted as counsel to Hennessy Capital.
-
June 23, 2017
Constellation Alpha Capital Corp. announced the closing of its initial public offering in the amount of $143,750,000. EG&S acted as counsel to Constellation.
-
June 21, 2017
Great Basin Scientific Inc. announced the closing of their Registered Direct offering in the amount of $2,619,003. EG&S acted as counsel to the lead Investor.
-
June 16, 2017
Interpace Diagnostics Group, Inc. announced the closing of its underwritten public offering in the amount of $13,700,000. EG&S acted as counsel to Maxim Group LLC, the sole book-running manager.
-
June 12, 2017
Client Alert: New York Paid Family Leave Law Deductions Should Start July 1, 2017
The PFL program – both the amount of leave time available and the monetary benefits – will be phased in beginning on January 1, 2018. However, prudent employers will ACT NOW to ensure they are on the same page with their payroll providers regarding deductions from payroll that should commence on July 1, 2017.
Click here to read the alert.
-
June 12, 2017
Client Alert: New York Enacts Paid Family Leave Law
New York’s Paid Family Leave (“PFL”) law will be phased in beginning on January 1, 2018. The law will be the most comprehensive in the country, providing paid leave to virtually all employees in New York, regardless of the size of the employer. The pertinent features of the PFL law are summarized here.
-
June 07, 2017
KBL Merger Corp. IV announced the closing of its initial public offering in the amount of $100,000,000. EG&S acted as counsel to KBL.
-
June 07, 2017
H-1B Visas and New Developments in Immigration Law
The United States Immigration and Citizenship Services (“USCIS”) recently announced that the H–1B work visa quota was exhausted for the fiscal year 2018 within the first four application days. The previous year, 85,000 H-1B visas were made available for new hires and approximately 236,000 requests were filed; a lottery was conducted and effectively 36% of all submitted H-1B visa requests were eligible. Nearly two-thirds of H-1B candidates were not selected and may be out of legal options.
Click here to read more.